Novel Emerging Investigational Treatment Strategies for Patients With Myelofibrosis

Decera Clinical Education Oncology Podcast · Nov 30, 2023 · 19m

In this episode, Jacqueline S. Garcia, MD, discusses novel agents and strategies in clinical trial development for treating patients with myelofibrosis, including:

Navitoclax (BCL-XL/BCL-2 inhibitor)

Pelabresib (BET inhibitor)

Imetelstat (telomerase inhibitor)

Luspatercept (erythroid maturation agent)

Additional strategies

Presenter:

Jacqueline S. Garcia, MD

Assistant Professor of Medicine

Harvard Medical School

Dana-Farber Cancer Institute

Boston, Massachusetts

Link to the full program here. https://bit.ly/47z8WCV

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information…